The anemia drugs market is experiencing strong growth as healthcare systems worldwide prioritize the management of anemia caused by nutritional deficiencies, chronic diseases, and genetic disorders. Anemia affects millions globally and remains one of the most common blood-related conditions, prompting expanded research and investment in drug development. Increasing awareness, improved...